Abstract

α-Synucleinopathies are characterized by autonomic dysfunction and motor impairments. In the pure autonomic failure (PAF), α-synuclein (α-Syn) pathology is confined within the autonomic nervous system with no motor features, but mouse models recapitulating PAF without motor dysfunction are lacking. Here, we show that in TgM83+/− mice, inoculation of α-Syn preformed fibrils (PFFs) into the stellate and celiac ganglia induces spreading of α-Syn pathology only through the autonomic pathway to both the central nervous system (CNS) and the autonomic innervation of peripheral organs bidirectionally. In parallel, the mice develop autonomic dysfunction, featured by orthostatic hypotension, constipation, hypohidrosis and hyposmia, without motor dysfunction. Thus, we have generated a mouse model of pure autonomic dysfunction caused by α-Syn pathology. This model may help define the mechanistic link between transmission of pathological α-Syn and the cardinal features of autonomic dysfunction in α-synucleinopathy.

Autonomic dysfunction is a feature of some α-synucleinopathies, but there are no models of pure autonomic dysfunction associated with α-synuclein. Here the authors describe a mouse model of pure autonomic dysfunction without motor dysfunciton by injection of pre-formed fibrils of α-synuclein to the stellate and celiac ganglia.

Details

Title
Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy
Author
Xue-Jing, Wang 1 ; Ming-Ming, Ma 2 ; Le-Bo, Zhou 1 ; Xiao-Yi, Jiang 1 ; Miao-Miao, Hao 1 ; Teng Robert K F 3 ; Wu Erxi 4   VIAFID ORCID Logo  ; Bei-Sha, Tang 5 ; Jia-Yi, Li 6 ; Jun-Fang, Teng 1   VIAFID ORCID Logo  ; Xue-Bing, Ding 7 

 The First Affiliated Hospital of Zhengzhou University, Department of Neurology, Zhengzhou, China (GRID:grid.412633.1); Zhengzhou University, Institute of Parkinson and Movement Disorder, Zhengzhou, China (GRID:grid.207374.5) (ISNI:0000 0001 2189 3846) 
 Affiliated People’s Hospital of Zhengzhou University, Henan Provincial People’s Hospital, Department of Neurology, Zhengzhou, China (GRID:grid.414011.1) 
 Shenzhen University, Collage of Electronic and Information Engineering, Shen Zhen, China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649) 
 Baylor Scott & White Health, Neuroscience Institute and Department of Neurosurgery, Temple, USA (GRID:grid.486749.0) (ISNI:0000 0004 4685 2620) 
 Xiangya Hospital, National Clinical Research Center for Geriatric Disorders, Changsha, China (GRID:grid.452223.0) (ISNI:0000 0004 1757 7615); School of Life Sciences, Central South University, Center for Medical Genetics, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
 Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, Neural Plasticity and Repair Unit, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Institute of Health Sciences, China Medical University, Shenyang, China (GRID:grid.412449.e) (ISNI:0000 0000 9678 1884) 
 The First Affiliated Hospital of Zhengzhou University, Department of Neurology, Zhengzhou, China (GRID:grid.412633.1); Zhengzhou University, Institute of Parkinson and Movement Disorder, Zhengzhou, China (GRID:grid.207374.5) (ISNI:0000 0001 2189 3846); School of Life Sciences, Central South University, Center for Medical Genetics, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2357413036
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.